Contents
Issue 159 • October 2025
In association with
In Depth
China takes lead in CGT trials amid Western funding challenges
As US funding falters, mRNA cancer vaccine pioneers face new hurdles
Europe’s cannabis pharmaceuticals market matures amid cautious investment
Animal testing alternatives to dominate, but not overnight
One platform can bring countless gains to clinical trial financial management
Cystic fibrosis market forecast to reach $16.0bn by 2034 in the 7MM